When Laura Ehrlich gave birth to her first child in 2020, the COVID-causing virus wasn’t the only threat facing her son. Born ...

THIRUVANANTHAPURAM: With recurrent Nipah outbreaks leaving more questions than answers, the state has launched a critical sero-surveillance initiative aimed at ...

In a new study, Yale School of Medicine (YSM) researchers unveiled a novel diagnostic method for detecting leptospiral ...

Imagine you are developing antibodies—drugs precisely aimed at a target, for example a viral protein or onco-marker. You test a series of antibodies and find that some work, while others do not.

Antibodies are the critical targeting agents of the immune system and the crux of immune therapy and vaccine development, but studying them is slow, expensive and labor-intensive. Now, researchers at ...

A, a 57-year-old homemaker, has occasionally misplaced items or struggled to recall people’s names for the past year.

FDA approval extends the indication of Evkeeza to treat younger patients with homozygous hypercholesterolemia (HoFH) HoFH is an inherited ...

Tim Friede's brave decision to inject himself with snake venom may be a gamechanger for creating a universal antivenom.

In a new study, Yale School of Medicine (YSM) researchers unveiled a novel diagnostic method for detecting leptospiral ...

Some parents have reported positive changes in their kids after giving them the drug, but experts remain concerned about a ...

Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibo ...

When Louise Mountford was blue-lighted to hospital in an ambulance with agonising pain just below her right ribs, she was convinced something in her stomach was about to burst. ‘I normally had a high ...